Scientists build a genetic map of myeloma to outsmart relapse
NCT ID NCT07582354
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study collects medical and genetic information from 520 people with multiple myeloma to better understand why the disease progresses or comes back. Researchers will analyze DNA and RNA from patient samples to find patterns linked to treatment response. The goal is to create a detailed map of the disease that could lead to more personalized therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA MULTIPLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS AOU Policlinico Sant'Orsola
RECRUITINGBologna, Bo, 40138, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.